{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:43:39Z","timestamp":1780638219942,"version":"3.54.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,3]]},"DOI":"10.7759\/cureus.21864","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T13:14:58Z","timestamp":1643894098000},"source":"Crossref","is-referenced-by-count":1,"title":["Methazolamide Associated Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis in a Female of Caucasian Descent"],"prefix":"10.7759","author":[{"given":"Amarah","family":"Baluch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeed R","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Warda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishab","family":"Sippy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance Database in Korea","volume":"11","author":"Yang MS","year":"2016","unstructured":"Yang MS, Lee JY, Kim J, et al.. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance Database in Korea. PLoS One. 2016, 11:e0165933. 10.1371\/journal.pone.0165933","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-018-0052-2","article-title":"Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"19","author":"Tangamornsuksan W","year":"2019","unstructured":"Tangamornsuksan W, Lohitnavy M. Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis: a systematic review and meta-analysis. Pharmacogenomics J. 2019, 19:286-294. 10.1038\/s41397-018-0052-2","journal-title":"Pharmacogenomics J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.540","article-title":"Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"145","author":"Gueudry J","year":"2009","unstructured":"Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009, 145:157-162. 10.1001\/archdermatol.2009.540","journal-title":"Arch Dermatol"},{"key":"ref4","unstructured":"What are the most common causes of Stevens-Johnson syndrome?. (2020). Accessed. 12\/16\/2021: https:\/\/www.jwatch.org\/na50905\/2020\/02\/18\/what-are-most-common-causes-stevens-johnson-syndrome."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2015.25","article-title":"HLA-B*59:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese","volume":"16","author":"Yang F","year":"2016","unstructured":"Yang F, Xuan J, Chen J, et al.. HLA-B*59:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese. Pharmacogenomics J. 2016, 16:83-87. 10.1038\/tpj.2015.25","journal-title":"Pharmacogenomics J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701753664","article-title":"Stevens-Johnson syndrome: pathogenesis, diagnosis, and management","volume":"40","author":"Hazin R","year":"2008","unstructured":"Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Med. 2008, 40:129-138. 10.1080\/07853890701753664","journal-title":"Ann Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol. 2013, 69:187.e1-187.e16. 10.1016\/j.jaad.2013.05.002","journal-title":"J Am Acad Dermatol"},{"key":"ref8","unstructured":"Stevens-Johnson syndrome and toxic epidermal necrolysis. Management, prognosis, and long-term sequelae - UpToDate. (2021). Accessed: 12\/16\/2021: https:\/\/www.uptodate.com\/contents\/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-lo...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/81123-methazolamide-associated-stevens-johnson-syndrometoxic-epidermal-necrolysis-in-a-female-of-caucasian-descent","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:30Z","timestamp":1707507870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/81123-methazolamide-associated-stevens-johnson-syndrometoxic-epidermal-necrolysis-in-a-female-of-caucasian-descent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.21864","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}